Company or institution

Protagonist Therapeutics, Inc.

Save Like

82 applicationsfiled 2013 to 2025

Allowance rate

62%

−14 pts vs the USPTO range 49% to 73%

Rejections before allowance

1.1

−0.4 vs the USPTO

Months to first action

10.8 mo

−7.8 vs the USPTO

Needed an RCE

30%

+3 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

C07K Peptides53 apps

A61P Therapeutic activity of compounds15 apps

A61K Medical preparations13 apps

G01N Investigating or analysing materials1 apps

Art units

165828 apps

165428 apps

167512 apps

OPAP7 apps

16111 apps

16331 apps

Examiners met

The examiners seen most, and how it went with each

Kristina M Hellman10 apps

78%

Erinne R Dabkowski10 apps

33%

Julie Ha9 apps

100%

Docket Central8 apps

n/a

Sergio Coffa8 apps

60%

Amber D Steele6 apps

83%

Fred H Reynolds5 apps

60%

Jia-Hai Lee2 apps

100%

Bars show the share of decided applications that were allowed.

Unlock the examiners this company meetsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who represents them

Law firms and agents on their applications

COOLEY LLP / Protagonist Therapeutics, Inc.52 apps

53%

Janssen BioPharma12 apps

63%

Takeda Pharmaceuticals International Co.6 apps

n/a

WOLF GREENFIELD & SACKS, P.C.6 apps

100%

Lathrop GPM LLP/J&J3 apps

100%

DAVID A. LANE, JR.2 apps

100%

BakerHostetler1 apps

100%

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

Application	Title	Filed	Status	Rejections	RCEs	To 1st action
19627502	FORMULATIONS OF A HEPCIDIN PEPTIDE ANALOGUE	2026-09-24	Pending	0	0	n/a
19695916	ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMAT…	2026-06-02	Pending	0	0	n/a
19588790	Human Interleukin (IL)-17 Cytokine Binding Peptides	2026-05-19	Pending	0	0	n/a
15499964	Method and apparatus for adaptive signal processing	2012-01-10	Allowed	1	0	12.0 mo
15225048	Composition and method for controlled release	2015-02-11	Abandoned	4	1	23.0 mo
15753233	Distributed ledger transaction verification	2018-03-12	Allowed	3	0	20.0 mo
15701758	Thermal management of battery assemblies	2021-04-13	Pending	2	1	17.0 mo
15876703	Machine learning model for anomaly detection	2012-05-14	Allowed	1	0	14.0 mo
15839531	Wireless power transfer coil arrangement	2015-06-15	Abandoned	4	1	25.0 mo
15647259	Catalyst for selective hydrogenation	2018-07-16	Allowed	3	0	22.0 mo

Unlock all 82 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in